How Patents Flagged for Delisting Can Still Delay Generic Competition
This Viewpoint discusses the legal entanglements that can block generic drug competition on patents flagged for delisting.
from JAMA Health Forum New Online https://ift.tt/RxaZLdV
from JAMA Health Forum New Online https://ift.tt/RxaZLdV
Comments
Post a Comment